Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
ZOLEDRONAT Accord onco Inf Konz 4 mg/5ml Durchstf
Drug
Zoledronat Accord onco 4 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung
Knochenmetastasen solider Tumore und multiples Myelom, maligne Hyperkalzämie
07.99.0. – various
HAM – Human medicine
KOPA – Parenteral concentrate
S – synthetic products for human use
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
5/23/2019
12/31/9999
Dosage strength
Zoledronat Accord onco 4 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung
Knochenmetastasen solider Tumore und multiples Myelom, maligne Hyperkalzämie
01
Z – approved
Package
7680670710015
No information made available
A/R – Authorised / referenced
1 vial(s)
001
Z – approved
Declaration
Component
4 mg acidum zoledronicum
acidum zoledronicum monohydricum
acidum zoledronicum monohydricum
mannitolum
natrii citras anhydricus
aqua ad iniectabile
6.41 mg natrium
natrii citras anhydricus
aqua ad iniectabile
6.41 mg natrium
Spezialitätenliste***
SL
-
-
131.55
None
No
10%
Yes
Authorisation holder
7601001405677
Accord Healthcare AG
Wuhrmattstrasse 23
4103 Bottmingen (BL)
Wuhrmattstrasse 23
4103 Bottmingen (BL)
Date of revision of the text
7/4/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.